Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $59.88 - $59.88 | $131,736 |
| 2024-11-11 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $12.13 - $12.13 | $26,686 |
| 2024-11-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 10000 | $48.97 - $48.97 | $489,699 |
| 2024-11-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 10000 | $21.65 - $21.65 | $216,499 |
| 2024-10-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 10000 | $46.28 - $46.28 | $462,800 |
| 2024-10-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 10000 | $21.65 - $21.65 | $216,500 |
| 2024-10-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
S | Common Stock | D | 11000 | $46.28 - $46.28 | $509,080 |
| 2024-10-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
M | Common Stock | A | 11000 | $3.29 - $3.29 | $36,190 |
| 2024-09-27 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | A | 830 | $0.00 - $0.00 | $0 |
| 2024-09-18 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
J | Common Stock | D | 7250 | $0.00 - $0.00 | $0 |
| 2024-09-17 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | D | 1170 | $0.00 - $0.00 | $0 |
| 2024-08-26 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
S | Common Stock | D | 3101 | $35.71 - $35.71 | $110,736 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 150 | $38.50 - $38.50 | $5,775 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 150 | $5.86 - $5.86 | $879 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 10000 | $38.67 - $38.67 | $386,700 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 10000 | $21.65 - $21.65 | $216,500 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Hunt Hazel
(Chief Scientific Officer) |
M | Common Stock | A | 60000 | $2.81 - $2.81 | $168,600 |
| 2024-08-01 | CORCEPT THERAPEUTICS INC | Hunt Hazel
(Chief Scientific Officer) |
F | Common Stock | D | 34773 | $37.94 - $37.94 | $1,319,287 |
| 2024-07-31 | CORCEPT THERAPEUTICS INC | BELANOFF JOSEPH K
(Chief Executive Officer) |
M | Common Stock | A | 450000 | $3.29 - $3.29 | $1,480,500 |
| 2024-07-31 | CORCEPT THERAPEUTICS INC | BELANOFF JOSEPH K
(Chief Executive Officer) |
F | Common Stock | D | 259583 | $38.67 - $38.67 | $10,038,074 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
S | Common Stock | D | 5000 | $32.49 - $32.49 | $162,452 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
M | Common Stock | A | 5000 | $11.35 - $11.35 | $56,750 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 10000 | $32.49 - $32.49 | $324,900 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 10000 | $21.65 - $21.65 | $216,500 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
S | Common Stock | D | 11000 | $32.49 - $32.49 | $357,390 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
M | Common Stock | A | 11000 | $3.29 - $3.29 | $36,190 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $32.81 - $32.81 | $72,182 |
| 2024-07-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
| 2024-06-24 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
J | Common Stock | D | 1000 | $0.00 - $0.00 | $0 |
| 2024-06-24 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | D | 4300 | $0.00 - $0.00 | $0 |
| 2024-06-04 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
M | Common Stock | A | 14000 | $3.29 - $3.29 | $46,060 |
| 2024-06-04 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
F | Common Stock | D | 8174 | $32.87 - $32.87 | $268,679 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
F | Common Stock | D | 724 | $30.17 - $30.17 | $21,843 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
A | Common Stock | A | 3636 | $31.30 - $31.30 | $56,903 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
S | Common Stock | D | 5000 | $30.18 - $30.18 | $150,916 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
M | Common Stock | A | 5000 | $11.35 - $11.35 | $56,750 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
F | Common Stock | D | 488 | $30.17 - $30.17 | $14,722 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
A | Common Stock | A | 2464 | $31.30 - $31.30 | $38,561 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $30.21 - $30.21 | $66,462 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
F | Common Stock | D | 823 | $30.17 - $30.17 | $24,829 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 10000 | $32.00 - $32.00 | $320,000 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 10000 | $19.26 - $19.26 | $192,600 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Mokari Atabak
(Chief Financial Officer) |
F | Common Stock | D | 571 | $30.17 - $30.17 | $17,227 |
| 2024-06-03 | CORCEPT THERAPEUTICS INC | Mokari Atabak
(Chief Financial Officer) |
A | Common Stock | A | 2896 | $31.30 - $31.30 | $45,322 |
| 2024-05-28 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
S | Common Stock | D | 11000 | $30.39 - $30.39 | $334,294 |
| 2024-05-28 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
M | Common Stock | A | 11000 | $3.29 - $3.29 | $36,190 |
| 2024-05-28 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
S | Common Stock | D | 30000 | $32.00 - $32.00 | $960,000 |
| 2024-05-28 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
M | Common Stock | A | 30000 | $19.26 - $19.26 | $577,800 |
| 2024-05-23 | CORCEPT THERAPEUTICS INC | WILSON JAMES N
(Director) |
G | Common Stock | D | 2000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |